Considering the similarities between the inhibition of survivin and mTOR in our HNSCC model and the extensively reported effects of mTOR inhibitors on cancer stem cells,37, 38 future studies should explore the combined therapeutic effect of YM155 on cancer stem cells. This evidence concerns the gene BIRC5 and head and neck squamous cell carcinoma.